{
    "organizations": [],
    "uuid": "cbc68407c0527ccd1120c109096e3d6e9f08c0fe",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-idera-pharmaceuticals-reports-q1-l/brief-idera-pharmaceuticals-reports-q1-loss-per-share-0-10-idUSASC0A0WG",
    "ord_in_thread": 0,
    "title": "BRIEF-Idera Pharmaceuticals Reports Q1 Loss Per Share $0.10",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Idera Pharmaceuticals Inc:\n* IDERA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* Q1 LOSS PER SHARE $0.10 * Q1 EARNINGS PER SHARE VIEW $-0.09 â€” THOMSON REUTERS I/B/E/S\n* AS OF MARCH 31, 2018, CASH AND CASH EQUIVALENTS TOTALED $107.5 MILLION COMPARED TO $112.6 MILLION AS OF DECEMBER 31, 2017\n* SEES EXISTING CASH, CASH EQUIVALENTS AND INVESTMENTS WILL FUND OPERATIONS INTO Q3 OF 2019 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T19:12:00.000+03:00",
    "crawled": "2018-05-10T17:48:51.037+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "idera",
        "pharmaceutical",
        "inc",
        "idera",
        "pharmaceutical",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "march",
        "cash",
        "cash",
        "equivalent",
        "totaled",
        "million",
        "compared",
        "million",
        "december",
        "see",
        "existing",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "fund",
        "operation",
        "q3",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}